Researchers at the University of Liverpool have demonstrated that a caecal microbiome transplant administered to broiler chicks at hatch significantly inhibits the transmission and intestinal colonisation of Campylobacter jejuni, a major cause of foodborne gastroenteritis in humans. Published in the journal Poultry Science and Management, the study provides proof-of-principle that modulating the early gut microbiome can reduce the bacterial burden in poultry at slaughter age. The findings suggest that microbial-based interventions may offer a practical route to lowering Campylobacter levels in commercial poultry production, potentially reducing the risk of human infection associated with poultry products.
Campylobacter jejuni is the most frequent cause of bacterial foodborne gastroenteritis worldwide, with poultry products serving as the primary source of infection. The bacteria colonise the intestinal tract of chickens, particularly the large blind caeca, leading to high levels of faecal shedding and rapid transmission within flocks. Despite various control strategies, including vaccines and feed-based approaches, significant reductions in Campylobacter burden have been difficult to achieve. The European Food Safety Authority’s 2008 baseline survey indicated that over 60% of retail chicken within the EU was contaminated with C. jejuni, highlighting the persistent challenge in controlling this pathogen in the food chain.
The study focused on a caecal microbiome transplant (CMT) approach, where digesta from healthy, Campylobacter-negative donor birds is collected and administered to recipient chicks. The rationale for this intervention is based on the understanding that the intestinal microbiome acts as a barrier to pathogen colonisation and drives the development of an effective mucosal immune system. Commercial broiler chickens typically acquire their early microbiome from the hatchery environment, which is often dominated by opportunistic pathogens such as Enterococcus and Enterobacteriaceae. This lack of diversity is associated with poor gut health and increased susceptibility to Campylobacter infection.
In the experimental design, Ross 308 broiler chicks were divided into three treatment groups: those receiving CMT, those treated with a commercial microflora competitive exclusion product called Aviguard, and untreated controls. The CMT was prepared from pooled caecal digesta of five 7-week-old healthy experimental control animals, confirmed to be Campylobacter-negative. The transplant was delivered orally within four hours of hatch. At 21 days of age, the birds were challenged with C. jejuni M1 using a seeder bird infection model, where two randomly selected birds from each group were dosed with the pathogen to simulate natural flock transmission.
The results showed that CMT treatment led to a significant reduction in Campylobacter transmission and colonisation compared to both the Aviguard-treated group and the untreated controls. In the seeder bird challenge model, birds receiving CMT had significantly lower levels of C. jejuni in the caeca and ileum at 35 days of age. The inhibition of colonisation was reproducible across multiple experiments, with effects ranging from complete inhibition to a significant reduction in intestinal load of up to 3 log10. CMT was found to be significantly more effective than Aviguard in reducing both transmission and final bacterial load, suggesting that the complexity and diversity of the whole microbiome transplant provide a stronger protective effect than defined commercial preparations.
Furthermore, the study investigated the extra-intestinal spread of C. jejuni, a phenomenon where the bacteria can move beyond the gut to tissues such as the liver and spleen. No birds receiving CMT treatment were positive for C. jejuni in either spleen or liver tissue samples collected at post-mortem examination. In contrast, Aviguard-treated and hatchery control groups showed higher frequencies of splenic and hepatic infiltration. This finding indicates that CMT not only reduces intestinal colonisation but also prevents the systemic spread of the pathogen, which is a critical factor in understanding the overall health impact of Campylobacter infection in poultry.
In a direct challenge model, where birds were individually dosed with C. jejuni, CMT did not completely prevent colonisation but did inhibit its establishment. Fewer CMT-treated birds were colonised at 4 days post-infection, and those that were colonised had lower bacterial numbers. By 10 days post-challenge, however, the caecal loads in CMT birds were similar to untreated controls. The study highlights the difference between inhibiting transmission in a flock setting and preventing individual infection, with the former being more relevant to commercial production scenarios.
The mechanism behind the protective effect of CMT is likely multifactorial. The transplant modifies the composition of the intestinal microbiome, increasing diversity and reducing the levels of Enterobacteriaceae, which are associated with poor gut health and increased susceptibility to Campylobacter. The reduction in these opportunistic pathogens may create a less favourable environment for C. jejuni colonisation. Additionally, the early acquisition of a diverse microbiome may drive the development of the mucosal immune system, enhancing the host’s ability to restrict pathogen growth and spread. The study notes that while the exact protective taxa have not been identified, the CMT serves as a valuable tool for discovering specific bacterial species that contribute to gut health and pathogen resistance.
The implications of these findings extend beyond the immediate control of Campylobacter in poultry. The authors suggest that rational, targeted microbial interventions, guided by microbiome analysis, could be developed to reduce the burden of campylobacteriosis. While the caecal transplant itself is not a practical solution for commercial hatcheries, it provides a proof-of-principle and a platform for identifying effective probiotics or defined consortia that can be used in industry.
Limitations of the study include the use of experimental conditions that may not fully replicate the complexity of commercial broiler flocks. The seeder bird model, while closer to natural transmission than direct challenge, still involves controlled variables that may not account for all factors influencing Campylobacter spread in real-world settings. Further research is needed to identify the specific mechanisms by which the transplanted microbiota inhibits Campylobacter, whether through competitive exclusion, metabolic interactions, or immune modulation.
The study contributes to the growing body of evidence supporting the role of the gut microbiome in animal health and food safety. By demonstrating that early microbiome manipulation can reduce pathogen burden, the research opens new avenues for developing sustainable control strategies for Campylobacter and other enteric pathogens. The findings underscore the importance of understanding the complex interactions between the host, pathogen, and microbiome in developing effective interventions.
In conclusion, the caecal microbiome transplant significantly reduces Campylobacter jejuni transmission and colonisation in broiler chickens, offering a viable strategy for reducing the risk of human infection. The study highlights the potential of microbiome modulation as a tool for controlling foodborne pathogens and provides a foundation for the rational development of microbial interventions. While further work is needed to identify the specific protective mechanisms and translate these findings into commercial practice, the results represent a significant step forward in the fight against campylobacteriosis.
To establish uniform baseline microbiomes and prevent accidental environmental contamination prior to treatment, the researchers sanitized embryonated Ross 308 eggs using a strict decontamination protocol. Eggs were immersed for two to three minutes in a one percent Ambicide solution maintained between thirty-eight and forty-one degrees Celsius, air-dried, and wiped with one percent peracetic acid before sterile incubation. The team maintained relative humidity between forty-five and fifty-five percent for eighteen days before increasing humidity to sixty to seventy percent for hatching.
The researchers verified the consistency of this protection across additional trials. In a second experiment tracking nineteen transplant recipients and nineteen control broilers, cloacal swabs monitored bacterial shedding at two, five, eight, and twelve days following seeder exposure. In a third trial evaluating ten treated chicks alongside twelve untreated controls, shedding was measured across ten days. Notably, the third experiment resulted in no detectable transmission or caecal colonisation among birds given the transplant, whereas control groups exhibited expected colonisation rates. Bacterial monitoring relied on cloacal swabbing combined with enrichment in Exeter broth and plating onto selective blood-free agar under microaerobic conditions.
Understanding these microbial dynamics is critical because risk modeling indicates that achieving a three-log reduction in caecal Campylobacter levels among broilers lowers human illnesses by fifty-eight percent. The administered caecal transplant comprised nearly five hundred amplified sequence variants representing distinct bacterial taxa, establishing a complex ecological barrier that conventional, cultured competitive exclusion formulations lack. Although identifying specific protective strains remains an ongoing challenge, the whole-microbiome approach demonstrates that early community complexity suppresses pathogen establishment during the vulnerable post-hatch rearing window without requiring antimicrobial treatments.
Subject of Research: Caecal microbiome transplant inhibits transmission and intestinal colonisation of Campylobacter jejuni in broiler chickens
Article Title: Caecal microbiome transplant inhibits transmission and intestinal colonisation of Campylobacter jejuni in broiler chickens
Article References: Gilroy, R., Chaloner, G., Wedley, A., Richards-Rios, P., Pottenger, S., & Wigley, P. (2026). Caecal microbiome transplant inhibits transmission and intestinal colonisation of Campylobacter jejuni in broiler chickens. Poultry Science and Management, 3(1), Article 13. https://doi.org/10.1186/s44364-026-00031-8
Image Credits: AI Generated
DOI: 10.1186/s44364-026-00031-8
Keywords: Caecal, microbiome, transplant, inhibits, transmission, intestinal, colonisation, Campylobacter, jejuni, broiler, chickens
Cite Scienmag News
Morgan Morrow. (November 18, 2026). Gut Microbiome Transplant Reduces Campylobacter Spread in Broilers. Scienmag. https://scienmag.com/gut-microbiome-transplant-reduces-campylobacter-spread-in-broilers/
Morgan Morrow. "Gut Microbiome Transplant Reduces Campylobacter Spread in Broilers." Scienmag, 18 November 2026, https://scienmag.com/gut-microbiome-transplant-reduces-campylobacter-spread-in-broilers/. Accessed 18 November 2026.
Morgan Morrow. "Gut Microbiome Transplant Reduces Campylobacter Spread in Broilers." Scienmag. November 18, 2026. https://scienmag.com/gut-microbiome-transplant-reduces-campylobacter-spread-in-broilers/








